date:May 17, 2012
elves from others based on health claims. The question is whether industry will then recognize that for true innovation they will need the 13.5. or 14 claim route.
For certain indications like weight management, gut, brain and joint health this would definitely be necessary, because there are hardly any 13.1 claims available highlighting the specific health message of such products.
We expect a second wave of innovation, demanding more thinking about high level substantiation, new clinical tri